RxDoctor Payments Data

Mary Caroline Imbs, DO

Obstetrics & Gynecology · Houston, TXNPI 1366970089

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $229, more than ten times the $17 reported in 2021. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.

$366in general payments, 2019–2025

Across 16 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$56
  • Organon$56
  • Aspira Women's Health Inc$54
  • Shield Therapeutics Inc$53
  • Hologic Sales And Service, LLC$34
  • Coopersurgical, Inc.$30
  • plus $85 from 4 others

What the payments were for

  • Food & beverage$366100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$366 in reported general payments places this provider in the 30th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Medicare billing

Part B allowed, 2024
$8,607
Medicare patients
86
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated15$8,375
Estradiol82$6,960
Estradiol (Twice Weekly)Estradiol30$2,951
ProgesteroneProgesterone, Micronized38$1,070
Clobetasol Propionate17$508
ValacyclovirValacyclovir Hcl16$382
Oxybutynin Chloride ErOxybutynin Chloride16$199
Gabapentin14$106

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →